R
Raymond R. Townsend
Researcher at University of Pennsylvania
Publications - 706
Citations - 47086
Raymond R. Townsend is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Blood pressure & Kidney disease. The author has an hindex of 84, co-authored 673 publications receiving 39096 citations. Previous affiliations of Raymond R. Townsend include University of Texas Medical Branch & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Catheter-Based Renal Denervation for Hypertension.
TL;DR: Whether untreated by medication for hypertension or on antihypertensive medication, renal denervation shows a clear, though moderate, blood pressure reduction, suggesting there is room for improvement in choosing the optimal patient for this approach to hypertension management.
Journal ArticleDOI
Pharmacodynamic study of the raf kinase inhibitor BAY 43–9006: Mechanisms of hypertension
M. L. Veronese,Keith T. Flaherty,Raymond R. Townsend,Ari Mosenkis,Ross Zimmer,Mark A. Rosen,Maryann Gallagher,Peter O'Dwyer +7 more
TL;DR: Mild hypertension occurs with BAY 43-9006 treatment, and may be associated with changes in catecholamines and with indices of vascular stiffness, but did not correlate with BP elevation.
Journal ArticleDOI
Effect of Heart Failure With Preserved Ejection Fraction on Nitric Oxide Metabolites
Payman Zamani,Benjamin French,Jeffrey Brandimarto,Paschalis-Thomas Doulias,Ali Javaheri,Julio A. Chirinos,Kenneth B. Margulies,Raymond R. Townsend,Nancy K. Sweitzer,James C. Fang,Harry Ischiropoulos,Thomas P. Cappola +11 more
TL;DR: HFpEF participants have reduced NOm compared with HFrEF in this matched cohort, which might suggest either compromised endothelial function or poor dietary intake.
Research Article Comparison of an in-pharmacy automated blood pressure kiosk to daytime ambulatory blood pressure in hypertensive subjects
TL;DR: The PharmaSmart PS-2000 closely approximated mean daytime ambulatory BP, supporting the use of serial readings from this device in the assessment of BP, and in-pharmacy device results were similar to automated office results.
Journal ArticleDOI
Changes in lipolytic sensitivity following repeated epinephrine infusion in humans
TL;DR: Repeated epinephrine treatment decreased basal glycerol rate of appearance and the lipolytic response to epinphrine in lean and obese subjects and increased plasma insulin concentration may be the mechanism.